All relevant data are within the paper and its Supporting Information files.

Introduction {#sec006}
============

The World Health Organization defines sexuality as a state of physical, emotional, mental and social well-being; a central aspect of "being human" that encompasses the possibility of having pleasurable and safe sexual experiences \[[@pone.0226404.ref001], [@pone.0226404.ref002]\]. Although sexual functioning is an essential aspect of human life, sexual problems are pervasive, and can result in severe consequences for the individual (and potentially their partner), if not addressed. Sexual dysfunction, defined as difficulty experienced by an individual or a couple during any stage of a normal [sexual activity](https://en.wikipedia.org/wiki/Human_sexual_activity), including physical pleasure, [desire](https://en.wikipedia.org/wiki/Sexual_desire), preference, arousal or [orgasm](https://en.wikipedia.org/wiki/Orgasm) \[[@pone.0226404.ref003], [@pone.0226404.ref004]\] has been associated with depression and other common mental disorders, relationship discord, poor self-rated health, infertility and overall quality of life \[[@pone.0226404.ref004]--[@pone.0226404.ref011]\]. Per the published literature, the prevalence of sexual dysfunctions is extremely high, and ranges from 10--63% across various global populations \[[@pone.0226404.ref007], [@pone.0226404.ref011]--[@pone.0226404.ref014]\].

Sexual problems are often multifactorial and can be classified into four broad categories, which are: biomedical (biological factors such as pregnancy, injury and disability, cardiovascular and other chronic diseases that can interfere with intercourse); intrapsychic (psychological elements within the individual, that influence their sexual expression e.g., values learned about one's body, nudity, "where babies come from", puberty, etc); interpersonal (factors that influence one's ability to engage in sexual relationships, such as communication difficulties with a partner, the extent to which partners share compatible visions of sex, eroticism, pleasure etc.); and socio-cultural/economic/political ('blueprints' for sexual norms, beliefs, values, practices and attitudes that are created and imposed on an individual based on the 'moral code' of their society. Includes religion.) \[[@pone.0226404.ref004], [@pone.0226404.ref015]\]. These four factors often overlap, and rarely occur in isolation to cause the sexual dysfunction \[[@pone.0226404.ref004]\]. Though sexual dysfunctions are common in both sexes, the greatest morbidity has been reported in women, particularly those in the African region \[[@pone.0226404.ref007]\]. In many African cultures, the discussion of sexual issues is generally considered a taboo \[[@pone.0226404.ref015], [@pone.0226404.ref016]\]; with conversations of sexuality heavily focused on religion, "moral behavior" and abstinence \[[@pone.0226404.ref015]\]. The mere mention of sex is often synonymous with deviant behavior \[[@pone.0226404.ref015]\], suppressing discussions of sexuality as a whole, and sexual dysfunctions in particular. Female sexual dysfunction (FSD), defined as persistent or recurring decrease in a woman's sexual desire, sexual arousal, painful sex (dyspareunia) and/or difficulty in or inability to achieve orgasm \[[@pone.0226404.ref007], [@pone.0226404.ref017]\], is rarely acknowledged in many societies and cultures \[[@pone.0226404.ref007], [@pone.0226404.ref018], [@pone.0226404.ref019]\]; though emerging literature suggests that the condition is quite common amongst African women in particular \[[@pone.0226404.ref007], [@pone.0226404.ref020], [@pone.0226404.ref021]\]. In the West African country of Ghana, the prevalence of FSD has been estimated to be as high as 72% \[[@pone.0226404.ref020], [@pone.0226404.ref021]\], 30% higher than the global prevalence \[[@pone.0226404.ref007]\]. These estimates however, are based on mostly urban heterosexual populations \[[@pone.0226404.ref021]\], limiting their generalizability to women in rural settings, who may be most vulnerable to adverse gynecological and mental health outcomes \[[@pone.0226404.ref022]--[@pone.0226404.ref025]\]. Moreover, the landmark evaluation of FSD amongst Ghanaian women \[[@pone.0226404.ref020]\], was based on a subpopulation of female urology patients, a clinical subgroup that would have greater predisposition for, and higher awareness of the dysfunction \[[@pone.0226404.ref026]\] than the average Ghanaian woman. Thus current prevalence estimates of FSD in Ghana may have some inherent biases.

The government of Ghana and the Ministry of Health, as part of the national agenda, have adopted sexual health as a component of reproductive health \[[@pone.0226404.ref016], [@pone.0226404.ref020]\]. Emphasis, however, has often been placed on sexually transmitted infections and contraception use, with little attention to, or a total neglect for sexual dysfunctions (SD) \[[@pone.0226404.ref020], [@pone.0226404.ref027]\]. In this paper, we describe the prevalence and severity of FSD amongst a group of Ghanaian women in the outpatient setting of the predominantly rural Volta region of Ghana. We describe the predictors of FSD severity and the care seeking behaviors of women with the condition; in the hopes of identifying possible opportunities for developing contextually appropriate interventions for this subpopulation of women.

Methods {#sec007}
=======

Study Setting {#sec008}
-------------

Ghana is a West African country with a population of 26.7 million and an annual gross domestic product (GDP) per capita income of \$4,100 \[[@pone.0226404.ref028]--[@pone.0226404.ref031]\]. With a land mass of 92,099 square miles, the country is comparable in size to the United Kingdom, with its' western border delineated by the [Ivory Coast](http://worldpopulationreview.com/countries/ivory-coast-population/), the north by [Burkina Faso](http://worldpopulationreview.com/countries/burkina-faso-population/), east by [Togo](http://worldpopulationreview.com/countries/togo-population/), and the Atlantic Ocean covering its' southernmost borders \[[@pone.0226404.ref031]\]. English is the official language, even though Ghanaians and non-Ghanaians of various ethnic, linguistic and religious backgrounds call the country home \[[@pone.0226404.ref028], [@pone.0226404.ref032], [@pone.0226404.ref033]\]. Similar to the 50 American states, Ghana is currently divided into 16 regions, with 45% of the population spread over large and rural expanses of land \[[@pone.0226404.ref028], [@pone.0226404.ref030], [@pone.0226404.ref034]--[@pone.0226404.ref036]\]. Volta Region, the site of the study, is considered part of the 'rural-savannah' agro-ecological zone of the country. The region is the farthest east, and shares boundaries with the Republic of Togo. Over a third of the residents (37.9%) are in rural settings and agriculture and fishery account for 71% of employment \[[@pone.0226404.ref036]\]. Volta is one of Ghana's 16 administrative regions, with Ho designated as its capital. The total population of the Ho capital is estimated at 177,281, which represents 8.4% of the region's total population. Females constitute 53% of the population, and an estimated 26.5% of the 11 and over population have no formal education compared to the national rate of 25.9%; with literacy rates for males being higher than that of females \[[@pone.0226404.ref037], [@pone.0226404.ref038]\].

A convenient sample of women in the outpatient setting of the Ho Teaching Hospital were recruited for this study. The Ho Teaching Hospital is a government-owned, 340-bed capacity hospital, equipped to provide services for several out-and in-patient departments including (but not limited to) surgery, medicine, obstetrics and gynaecology, diagnostics, paediatrics and psychiatry.

Eligibility criteria {#sec009}
--------------------

All women were encouraged to participate in this cross-sectional study, irrespective of their relationship status. To be eligible, participants had to be consenting adults over the age of 18years, who were seeking care in the outpatient setting of the Ho Teaching Hospital during the period of data collection, which spanned April 17^th^ 2019 to May 22^nd^ 2019. Women who were admitted, or had major mental or cognitive impairment, speech impairment and major morbidity like stroke and psychiatric illness were excluded from the study, as were those who refused consent. The study was approved by the University of Health and Allied Sciences' Research Ethics Committee, with permission obtained from the Ho Teaching Hospital administration. As specified and approved by the University of Health and Allied Sciences' Research Ethics Committee, we obtained written consent from all participants to conduct this study. All consent forms were kept separately from the de-identified survey questionnaires, in a secure location under the supervision of the final author. Keeping the signed consents separate from the survey questionnaires was to ensure that participants' responses could not be connected to their identities.

Sample size determination {#sec010}
-------------------------

Based on a prevalence estimate of 72%, an alpha of 0.05 and a 95% confidence interval, an estimated sample size of 301 was required to complete the study \[[@pone.0226404.ref039]\].

Data collection instrument & measures {#sec011}
-------------------------------------

### Demographics {#sec012}

A standard questionnaire (see [Appendix](#sec023){ref-type="sec"}) was used to collect socio-demographic data about participants' demographic (age, educational attainment, employment status, religious affiliation, residential setting), relational (marital status, parity), and recruitment (i.e. outpatient department recruited from e.g. surgery, medicine, obstetrics and gynaecology, etc.) characteristics.

### Sexual functioning {#sec013}

Female sexual function was assessed using the 19-item Female Sexual Function Index (FSFI) questionnaire \[[@pone.0226404.ref011], [@pone.0226404.ref040], [@pone.0226404.ref041]\]. With an internal consistency of 0.89--0.96, the FSFI is the most frequently used questionnaire for assessing FSD in various populations across the literature \[[@pone.0226404.ref011], [@pone.0226404.ref041]\]. The measure has been deemed reliable for Ghanaian populations, and used previously in clinical, community and population-based assessments of sexual functioning in Ghanaian women \[[@pone.0226404.ref018], [@pone.0226404.ref021]\]. The FSFI evaluates six domains of female sexual functioning: desire (2 items:Q1,Q2), arousal (4 items:Q3-Q6), lubrication (4 items: Q7-Q10), orgasm (3 items: Q11-Q13), satisfaction (3 items: Q14-Q16) and pain (3 items: Q17-Q19) during sexual intercourse. Study participants are asked to choose the response option that best suited their sexual function during the past four weeks. Scores for items 3--14 and 17--19 range from 0 ("No Sexual Activity") to 5 ("Very high" or "Almost always/ Always"), and for items 1, 2, 15 and 16, range from 1 ("Almost never/Never" or "Very low/None at all" to 5 ("Very high/satisfied" or "Almost always/Always"). Each domain is ascribed a factor (0.6 for desire, 0.3 for arousal & lubrication, and 0.4 for orgasm, satisfaction and pain) \[[@pone.0226404.ref011], [@pone.0226404.ref040], [@pone.0226404.ref041]\]. The scores for each domain are calculated by adding the scores of the individual domain items and multiplying the sum by the domain factor. Total score is obtained by adding the six domain scores. The full-scale score range is from 2.0 to 36.0, with lower scores indicative of poor sexual functioning. Since the typical cutoff of FSFI score of ≤26.55 for FSD is less sensitive in conservative settings, we used an FSFI score ≤23 to designate FSD \[[@pone.0226404.ref011]\], so as not to underestimate the FSD prevalence. Thus women with FSD had an FSFI Total score of 23 or lower, and "no FSD" was designated as an FSFI Total score \>23. We further used the following criteria to categorize FSD severity \[[@pone.0226404.ref011]\]: mild FSD (FSFI Total score 18--23), moderate FSD (FSFI Total score \<18 to \>10), severe FSD (FSFI Total score ≤10). Due to sample size restrictions, we combined the moderate and severe FSD groups in our analyses and defined "moderate/severe FSD" as an FSFI Total score below 18.

### Help seeking behaviors {#sec014}

Participants with FSD were further asked to indicate whether or not they sought help for their sexual dysfunction, the reasons they sought help, and the types of help sought. Help sought from medical providers were designated as "formal help" whereas "Informal help" was ascribed to friends, family and prayer camps. Responses of "Other" were prompted for further elaboration.

All surveys were interviewer led and completed in-person (i.e. face-to-face) with each respondent. A translated version of the questionnaire was used for those who were not English speaking. The questionnaire was translated into the local dialect, pre-tested to ensure accuracy of translation, and administered by trained study personnel. All interviews were conducted in a screen-protected and discrete study-designated area of the outpatient departments of the Ho Teaching Hospital where the study was conducted. Though there are many languages spoken in the Volta region, from our training and pre-testing phases preparatory to the study, we found most respondents could comfortably speak Ewe, Twi, English or combinations of these. We pretested the survey questionnaire in the following two steps: i) Interviewing of random respondents within the Ho Teaching Hospital to determine participants' language preferences and to ensure uniformity among study personnel, and 2) under the supervision of the senior author (BI), interviewers practiced administering the survey to ensure consistency of delivery and translation of questions by all study personnel.

### Statistical analyses {#sec015}

We considered in our analyses, several covariates that are associated with sexual functioning, including age, relationship status, parity, education, religious affiliation and residential setting (urban/rural). Univariate analyses and descriptive statistics were used to examine the frequencies and distributions of the study population by FSD group (Has FSD/No FSD), domain (desire, arousal, lubrication, orgasm, satisfaction, pain) and severity (mild, moderate, severe). Categorical variables were compared using chi-square (Х^2^) or Fisher's Exact tests, where appropriate, while comparisons of continuous outcomes were done using t-tests and Anova estimates, with a parametric distribution of FSD in the study sample.

Age was found to be associated with several other covariates and predictors, and was the most significant predictor of FSD outcome in this study. Adjusting for age only in logistic regression analyses gave us the most parsimonious models. Thus in our logistic regression models, we present both crude and age-adjusted effect estimates. All computations were done at the 95% confidence level, and we report odds ratios and their associated 95% confidence intervals. We used p \<0.05 to determine statistical significance for all analyses.

Results {#sec016}
=======

Demographics and FSD prevalence {#sec017}
-------------------------------

Of 407 women approached, 341 (83.8%) agreed and consented to participate in the study. Fourty one (12%) had incomplete questionnaires, where subjects declined further participation because they found the questionnaire exhausting or intrusive or because of time constraints. The attributes of the final 300 subjects are presented in [Table 1](#pone.0226404.t001){ref-type="table"}. The majority of participants were recruited from the Gynecological and General Outpatient departments of the Ho Teaching Hospital. As depicted, the prevalence of FSD was 48.3% (n = 145), with women who endorsed the dysfunction being significantly older than those without the dysfunction (mean age 34.0(+/-9.5) versus 29.3(+/-6.7) years; p\<0.001). Of the women with FSD, the majority (73.8%) were below the age of 40, with most (42.1%) spanning ages 30 and 39 years, and about a third (31.7%) between ages 18 and 29. Approximating the rural population of the Volta Region, over a third of the FSD women resided in rural settings (37.9% vs 20.6% p = 0.001) and tended to be multiparous, with a significantly greater proportion having at least three children (31.7% vs 18.1; p = 0.033), compared to those without FSD.

10.1371/journal.pone.0226404.t001

###### Demographic and FSD attributes of study population (n = 300).

![](pone.0226404.t001){#pone.0226404.t001g}

  ----------------------------------------------------------------------------------------------------------------------
                                             Has FSD\               No FSD\                p value       Total\
                                             FSFI score ≤23)\       FSFI score \>23\                     n = 300
                                             (n = 145, 48.3%)       (n = 155, 51.7%)                     
  ------------------------------------------ ---------------------- ---------------------- ------------- ---------------
  **Demographic Attributes (n,%)**                                                                       

  **Age, in years**\                         34.0 (+/-9.5)          29.3 (+/-6.7)          **\<0.001**   31.6 (+/-8.5)
  **mean (+/-SD)**                                                                                       

  18--29                                     46 (31.7)              80 (51.6)                            126 (42.0)

  30--39                                     61 (42.1)              61 (39.4)              **\<0.001**   122 (40.7)

  ≥40                                        38 (26.2)              14 (9.0)                             52 (17.3)

  Range                                      18--62                 18--49                               18--62

  **Relationship Status**                                                                  0.206         

  Married                                    90 (62.1)              92 (59.4)                            182 (60.7)

  Single                                     38 (26.2)              52 (33.5)              90 (30.0)     

  Co-habitating                              17 (11.7)              11 (7.1)               28 (9.3)      

  **Parity**\                                1.9 (+/-1.5)           1.3 (+/-1.2)           **\<0.001**   1.6 (+/-1.4)
  **mean (+/-SD)**                                                                                       

  0                                          37 (25.5)              53 (34.2)                            90 (30.0)

  1                                          23 (15.9)              33 (21.3)              **0.033**     56 (18.7)

  2                                          39 (26.9)              41 (26.5)                            80 (26.7)

  ≥3                                         46 (31.7)              28 (18.1)                            74 (24.7)

  Range                                      0--7                   0--5                                 0--7

  **Educational Attainment**                                                               **0.002**     

  No formal Education                        18 (12.4)              6 (3.9)                              24 (8.0)

  Basic Education\                           42 (29.0)              36 (23.2)                            78 (26.0)
  (Primary Grades 1--6)                                                                                  

  Secondary Education\                       39 (26.9)              35 (22.6)                            74 (24.7)
  (Junior/Senior High School grades 7--12)                                                               

  Tertiary Education\                        46 (31.7)              78 (50.3)                            124 (41.3)
  (University and Higher)                                                                                

  **Religious Affiliation**                                                                0.406         

  Christian                                  139 (95.9)             147 (94.8)                           286 (95.3)

  Muslim                                     5 (3.4)                4 (2.6)                              9 (3.0)

  Other                                      1 (0.7)                4 (2.6)                              5 (1.7)

  **Employment status**                                                                    0.148         

  Unemployed                                 32 (22.1)              46 (29.7)                            78 (26.0)

  Employed                                   113 (77.9)             109 (70.3)                           222 (74.0)

  Self-employed                              42 (37.2)              60 (55.0)                            102 (34.0)

  Employed by others                         71 (62.8)              49 (45.0)                            120 (40.0)

  **Residential Setting**                                                                  **0.001**     

  Urban setting                              90 (62.1)              123 (79.4)                           213 (71.0)

  Rural setting                              55 (37.9)              32 (20.6)                            87 (29.0)

  **Outpatient Setting recruited from**                                                    **0.001**     

  Gynecological                              63 (43.4)              56 (36.1)                            119 (39.7)

  General                                    40 (27.6)              20 (12.9)                            60 (20.0)

  Surgical                                   16 (11.0)              23 (14.8)                            39 (13.0)

  Dental                                     12 (8.3)               16 (10.3)                            28 (9.3)

  Ear/Nose/Throat                            7 (4.8)                17 (11.0)                            24 (8.0)

  Eye Clinic                                 7 (4.8)                23 (14.8)                            30 (10.0)

  **FSD Attributes (n,%)**                                                                               

  **FSD Domain Prevalence**                                                                              

  Desire                                     141 (97.2)             \-                                   141 (47.0)

  Arousal                                    116 (80.0)             \-                                   116 (37.8)

  Lubrication                                74 (51.0)              \-                                   74 (24.7)

  Orgasm                                     120 (82.8)             \-                                   120 (40.0)

  Satisfaction                               112 (77.2)             \-                                   112 (37.3)

  Pain                                       84 (57.9)              \-                                   84 (28.0)

                                             **Has FSD**\           **No FSD**\            **p value**   **Total**\
                                             **FSFI score ≤23)**\   **FSFI score \>23**\                 **n = 300**
                                             **(n = 145, 48.3%)**   **(n = 155, 51.7%)**                 

  **Number of FSD Domains endorsed**                                                                     

  One Domain                                 0 (0.0)                \-                                   0 (0.0)

  2 Domains                                  5 (3.4)                \-                                   5 (1.7)

  3 Domains                                  23 (15.9)              \-                                   23 (7.7)

  4 Domains                                  46 (31.7)              \-                                   46 (15.3)

  5 Domains                                  42 (29.0)              \-                                   42 (14.0)

  All 6 Domains                              29 (20.0)              \-                                   29 (9.7)

  **FSD Severity**                                                                                       

  Mild FSD (FSFI score 18 to 23)             105 (72.4)             \-                                   105 (35.0)

  Moderate FSD (FSFI score \<18 to \>10)     29 (20.0)              \-                                   29 (9.7)

  Severe FSD (FSFI score ≤10)                11 (7.6)               \-                                   11 (3.7)

  Moderate/Severe FSD (FSFI score \<18)      40 (27.6)                                                   40 (13.3)

  **Help Seeking Behaviors**                                                                             

  Sought Help for Sexual Dysfunction         17 (11.7)              \-                                   17 (5.7)

  Did not Seek Help                          128 (88.3)             \-                                   128 (42.7%)
  ----------------------------------------------------------------------------------------------------------------------

There were also significant differences in education between the groups. Three out of every 25 women with FSD (12.4%) had no formal education, compared to 1 in 25 (3.9%) uneducated women in the "No FSD" group; and the proportion of those with tertiary education was also lower for FSD women compared to those without the dysfunction (31.7% vs 50.3%; p = 0.002). The employment rates for women in the FSD group was slightly higher than those without the dysfunction, though the difference was not statistically significant (77.9% vs 70.3%; p = 0.148).

Amongst women with FSD, the most commonly endorsed domains were Desire (97.2%), Orgasm (82.8%) and Arousal (80.0%), with one in five (20%) women endorsing dysfunctions in all 6 domains. Forty women (27.6%), representing over a quarter of the sample, met the cut-off for moderate to severe FSD. Women with severe FSD were on average, significantly younger than the rest of the group ([Fig 1](#pone.0226404.g001){ref-type="fig"}). Six in 10 (63.6%) women with severe FSD was between the ages of 18 and 29; and 91% of all women with severe FSD were under the age of 40 ([Fig 1](#pone.0226404.g001){ref-type="fig"}). These age distributions were significantly greater than any of the others groups'.

![Boxplot of mean age by FSD severity, p\<0.001.](pone.0226404.g001){#pone.0226404.g001}

Age was found to be associated with several other covariates and predictors, and was the most significant predictor of FSD outcome in this study. Adjusting for age only in logistic regression analyses gave us the most parsimonious models, thus [Table 2](#pone.0226404.t002){ref-type="table"} shows crude and age-adjusted effect estimates for the predictors of FSD severity.

10.1371/journal.pone.0226404.t002

###### Predictors of Moderate/severe sexual dysfunction amongst women with female sexual dysfunction (n = 145).
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  ------------------------------------------------------------------------------------------------------------------------------------------------
  Moderate/Severe FSD[^†^](#t002fn001){ref-type="table-fn"}\   Crude Odds Ratio                        Age-Adjusted Odds Ratio
  (FSFI Score \<18)                                                                                    
  ------------------------------------------------------------ --------------------------------------- -------------------------------------------
  **FSD Domain**                                                                                       

  Desire Disorder (vs Not)                                     2.34 (95% CI: 0.07, 75.30; p = 0.63)    1.89 (95% CI: 0.06, 57.80; p = 0.72)

  Arousal Disorder (vs Not)                                    9.45 (95% CI: 0.74, 120.60; p = 0.08)   8.87 (95% CI: 0.70, 113.0; p = 0.09)

  Lubrication Disorder (vs Not)                                49.52 (95%CI: 9.27, 264.50; p\<0.001)   **45.38 (95%CI: 8.37, 246.00; p\<0.001)**

  Orgasm Disorder (vs Not)                                     n/a                                     n/a

  Satisfaction Disorder (vs Not)                               4.85 (95% CI: 1.15, 20.50; p = 0.03)    **4.69 (95% CI: 1.09, 20.20; p = 0.04)**

  Pain Disorder (vs Not)                                       15.81 (95%CI: 4.30, 58.20; p\<0.001)    **17.18 (95%CI: 4.50, 65.50; p\<0.001)**

  **Parity**                                                                                           

  0 children                                                   2.42 (95% CI:1.04, 5.65; p = 0.04)      **3.51 (95% CI: 1.37, 8.98; p = 0.009)**

  1--3 children                                                ref                                     ref

  ≥4 children                                                  1.84 (95% CI: 0.70, 4.82; p = 0.22)     1.64 (95% CI: 0.61, 4.39; p = 0.32)

  **Education**                                                                                        

  No formal Education                                          0.46 (95% CI: 0.14, 1.50; p = 0.20)     **0.27 (95% CI: 0.07, 0.97; p = 0.045)**

  Basic Education\                                             0.13 (95% CI: 0.04, 0.41; p = 0.001)    **0.09 (95% CI: 0.02, 0.31; p\<0.001)**
  (Primary Grades 1--6)                                                                                

  Secondary Education\                                         0.41 (95% CI: 0.16, 1.03; p = 0.06)     **0.31 (95% CI: 0.11, 0.83; p = 0.02)**
  (Junior/Senior High Schoolgrades 7--12)                                                              

  Tertiary Education\                                          ref                                     ref
  (University and Higher)                                                                              

  **Residential Setting**                                                                              

  Urban                                                        ref                                     ref

  Rural                                                        0.84 (95% CI: 0.39, 1.80; p = 0.66)     0.74 (95% CI: 0.34, 1.62; p = 0.45)
  ------------------------------------------------------------------------------------------------------------------------------------------------

^†^n = 40, using mild FSD (n = 105) as reference

n/a = unable to compute due to zero cells

FSD severity {#sec018}
------------

In both crude and age-adjusted models, women with lubrication, pain and satisfaction disorders had statistically greater odds of reporting moderate/severe FSD ([Table 2](#pone.0226404.t002){ref-type="table"}). Lubrication disorder was associated with 45 times the odds of moderate/severe FSD (95% CI: 8.37, 246.00; p\<0.001) whilst pain (OR: 17.18, 95% CI: 4.50, 65.50; p\<0.001) and satisfaction (OR: 4.69, 95% CI: 1.09, 20.20; p = 0.04) were lower in comparison, but highly significant. Compared to those with 1--3 children, women at both ends of the parity spectrum had higher odds of moderate/severe sexual dysfunction; though the effect estimate for those with no children (OR: 3.51; 95% CI: 1.37, 8.98; p = 0.009) was much greater than those with 4 or more offspring (OR:1.64; 95% CI: 0.61, 4.39; p = 0.32). It is important to note that 21.0% (n = 19) of women with no children were married.

Lower educational attainment and residing in a rural setting were, surprisingly, protective for moderate/severe FSD. At all levels of education, FSD women without tertiary training had consistently lower odds of reporting moderate/severe sexual dysfunction compared to those with university level education or higher. Residing in a rural setting was also associated with lower odds of moderate/severe FSD, though residential setting was not a significant predictor of the outcome.

Care seeking behaviors {#sec019}
----------------------

Out of the 145 women with FSD, 17 (11.7%) sought help for their dysfunction ([Table 1](#pone.0226404.t001){ref-type="table"}). Statistically significant predictors of FSD-related care seeking, depicted in [Table 3](#pone.0226404.t003){ref-type="table"}, included dissatisfied (age-adj. OR: 0.30, 95% CI: 0.10, 0.86; p = 0.03) or painful sex (age-adj OR: 5.91, 95% CI:1.29, 27.15; p = 0.02), having 4 more children (age-adj OR: 6.29; 95% CI: 1.53, 25.76; p = 0.01), or residing in a rural setting (age-adj. OR: 2.87, 95%CI: 1.00, 8.24; p = 0.05**)**.

10.1371/journal.pone.0226404.t003

###### Predictors and help seeking characteristics of women with female sexual dysfunction (n = 145)[^†^](#t003fn001){ref-type="table-fn"}.
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  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                      Crude Estimates                           Age-Adjusted Estimates
  ----------------------------------------------------------------------------------- ----------------------------------------- -----------------------------------------
  **FSD Severity**                                                                                                              

  Moderate/Severe FSD (vs Mild)                                                       2.02 (95%CI: 0.71,5.72; p = 0.19)         2.17 (95%CI: 0.75,6.29; p = 0.16)

  **FSD Domain**                                                                                                                

  Desire (vs Not)                                                                     n/a                                       n/a

  Arousal Disorder (vs Not)                                                           0.77 (95% CI: 0.17,3.51; p = 0.74)        0.79 (95% CI: 0.23, 2.69; p = 0.70)

  Lubrication Disorder (vs Not)                                                       2.33 (95%CI:0.69, 7.79; p = 0.17)         2.90 (95% CI: 0.97, 9.20; p = 0.06)

  Orgasm Disorder (vs Not)                                                            1.18 (95%CI:0.23, 6.00; p = 0.84)         0.79 (95% CI: 0.20, 3.10; p = 0.74)

  Satisfaction Disorder (vs Not)                                                      0.39 (95% CI: 0.13, 1.21; p = 0.10)       **0.30 (95% CI: 0.10, 0.86; p = 0.03)**

  Pain Disorder (vs Not)                                                              **5.11 (95%CI: 1.09,24.03; p = 0.04)**    **5.91 (95%CI: 1.29, 27.15; p = 0.02)**

  **Number of FSDs Endorsed**                                                                                                   

  Endorses \>4 FSDs (vs 1--4 FSDs)                                                    1.20 (95% CI: 0.44,3.30; p = 0.73)        1.26 (95%CI: 0.45, 3.53; p = 0.66)

  **Age**                                                                                                                       

  18--29 (vs 30--39)                                                                  1.62 (95% CI: 0.54,4.86; p = 0.39)        \-

  ≥40 (vs 30--39)                                                                     0.43 (95% CI: 0.08,2.18; p = 0.31)        \-

  **Parity**                                                                                                                    

  0 children (vs 1--3)                                                                **4.05 (95%CI: 1.11,14.80; p = 0.035)**   2.83 (95%CI: 0.65, 12.29; p = 0.17)

  ≥4 children (vs 1--3)                                                               **5.05 (95%CI: 1.31,19.50; p = 0.02)**    **6.29 (95%CI: 1.53, 25.76; p = 0.01)**

  **Education**                                                                                                                 

  No formal Education (vs Tertiary)                                                   n/a                                       n/a

  Basic Education (Primary Grades 1--6) (vs Tertiary)                                 0.75 (95% CI: 0.22,2.58; p = 0.65)        0.86 (95% CI: 0.25, 3.03; p = 0.82)

  Secondary Education (Junior/Senior High School grades 7--12) (vs Tertiary)          0.82 (95% CI: 0.24,2.82; p = 0.75)        0.96 (95% CI: 0.27, 3.39; p = 0.95)

  **Marital Status**                                                                                                            

  Single (vs Married)                                                                 1.50 (95% CI: 0.50,4.47; p = 0.47)        0.81(95%CI: 0.19,3.42; p = 0.78)

  Co-habitating (vs Married)                                                          0.50 (95% CI: 0.06,4.19; p = 0.52)        0.38 (95% CI: 0.04, 3.39; p = 0.38)

  **Residential Setting**                                                                                                       

  Rural (vs Urban)                                                                    2.64 (95% CI: 0.94,7.39; p = 0.07)        **2.87 (95%CI: 1.00, 8.24; p = 0.05)**

  **Help Seeking Characteristics**\                                                                                             
  **(n,%)**                                                                                                                     

  [\*](#t003fn003){ref-type="table-fn"}**Where help was sought (n = 17)**                                                       

  **Formal**                                                                          **12 (70.6%)**                            

  General Practitioner                                                                10 (83.3%)                                

  Gynecologist                                                                        2 (16.7%)                                 

  **Informal**                                                                        **4 (23.5%)**                             

  Friends                                                                             3 (75%)                                   

  Herbalist                                                                           1 (25%)                                   

  No response/Missing                                                                 1(5.9%)                                   

  [\*](#t003fn003){ref-type="table-fn"}**Reasons for seeking help (n = 17)**                                                    

  Condition is causing emotional strains                                              14 (82.4%)                                

  Condition is causing relationship/ marriage strains                                 2 (11.8%)                                 

  Advised to by relatives/friends/pastor                                              1 (5.8%)                                  

  [\*\*](#t003fn004){ref-type="table-fn"}**Reasons for not seeking help (n = 128)**                                             

  Don\'t know it is a medical condition                                               40 (31.3%)                                

  Thought it was normal                                                               37 (28.9%)                                

  Time constraints                                                                    24 (18.8%)                                

  Health provider cannot help me                                                      18 (14.1%)                                

  Other reason                                                                        1 (0.8%)                                  

  No response/Missing                                                                 8 (6.3%)                                  
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------

^†^n = 17 for sought care, using "did not seek care" (n = 128) as reference

n/a = unable to compute due to zero cells

\*asked of those who answered "Yes" to the question "Did you seek for help when you experienced the female sexual dysfunction?" (see [Appendix](#sec023){ref-type="sec"})

\*\*asked of those who answered "No" to the question "Did you seek for help when you experienced the female sexual dysfunction?" (see [Appendix](#sec023){ref-type="sec"})

Eight in ten women (82.4%) were prompted to seek help due to the emotional strain of the sexual dysfunction, 12% cited relationship strain as a prompt for their care-seeking, and one woman (5.8%) sought help upon the advice of her pastor ([Table 3](#pone.0226404.t003){ref-type="table"}). Of those who sought help, seven in 10 sought formal assistance from a healthcare provider, with the majority (83%) consulting a General Practitioner for their dysfunctions; and only 16.7% seeking the care of a Gynecologist.

Of the 128 women with FSD who did not seek help, about one in 3 (31.3%) indicated that they did not know their sexual dysfunction was a medical condition. Over a quarter (28.9%) "thought it was normal" to have FSD, and interestingly, 14.1% did not think a medical provider would be able to provide them with assistance.

Discussion {#sec020}
==========

Though human sexual function has requisite biological underpinnings, it is usually experienced as a complex interaction of biological, intrapsychic, interpersonal and socio-cultural/economic/political factors \[[@pone.0226404.ref004], [@pone.0226404.ref015]\]. In many parts of the world, sexuality is considered a sensitive topic, and sexual discussions-whether they be of displeasure or not, are discouraged. Female sexuality is especially taboo; particularly in religious countries like Ghana. Thus women with pathological disorders in sexual functioning may not seek and/or receive the diagnosis and treatment that they may need for their clinically diagnosable and treatable sexual disorders. This is the first study that to our knowledge, evaluates the prevalence, severity and help-seeking behaviors of women with FSD in the mostly rural and agrarian setting of the Volta region of Ghana. Almost half of the women in our study met the cutoff for female sexual dysfunction. The FSD prevalence estimate of 48.3% in our study, approximates the global prevalence of 40.9% \[[@pone.0226404.ref007]\] and is similar to rates reported for non-clinical, mostly urban Ghanaian females in heterosexual relationships (45.6%) who hailed from the Greater Accra, Ashanti, Western, Central, Brong-Ahafo and Eastern regions. \[[@pone.0226404.ref021]\]. Though often shrouded in taboo and stigma, research shows that sexual and reproductive health is fundamental to the economic development of nations, to people's health and survival, and to the wellbeing of humanity \[[@pone.0226404.ref042]\]. Compared to those in urban settings and of higher socio-economic status, women in rural settings, and those of lower socio-economic standing, tend to be more vulnerable to adverse physical, mental, obstetric and gynecological health outcomes \[[@pone.0226404.ref022], [@pone.0226404.ref043]--[@pone.0226404.ref053]\]. They often report poorer self-rated mental and physical health \[[@pone.0226404.ref043], [@pone.0226404.ref052]\], have less access to necessary obstetric care \[[@pone.0226404.ref022], [@pone.0226404.ref046], [@pone.0226404.ref047], [@pone.0226404.ref050]\], and have higher rates of trauma and mortality \[[@pone.0226404.ref023], [@pone.0226404.ref024], [@pone.0226404.ref046], [@pone.0226404.ref054]--[@pone.0226404.ref059]\]. Poor sexual functioning may further exacerbate these and other adverse health conditions in this subpopulation. Not surprisingly, women with FSD in our study were most likely to be rural residents, have lower educational attainment and on average, have more children than those without sexual dysfunctions. Given the associations between sexual health, economic growth and overall population health, future studies should engage government stakeholders and policy makers to incorporate sexual dysfunctions as a core component of the government's reproductive health agenda. The Ministry of Health's reproductive health policy could be expanded beyond the prevention of unwanted pregnancies and sexually transmitted infections \[[@pone.0226404.ref015], [@pone.0226404.ref016], [@pone.0226404.ref020]\] to more holistically encourage providers to discuss sexual health and sexual dysfunctions (both male and female forms) with their patients. We acknowledge that such a recommendation would require an enormous psycho-socio-cultural shift across all facets of the country's healthcare system, but

without such a strategy, it will be difficult to recognize the discriminant impact that sexual dysfunctions have on some of the most vulnerable members of Ghanaian society.

It is often assumed that sexual dysfunctions in women are associated with increasing age, the onset of menopause, and several associated hormonal changes \[[@pone.0226404.ref005], [@pone.0226404.ref006], [@pone.0226404.ref013], [@pone.0226404.ref060]--[@pone.0226404.ref065]\]. However, our results show that FSD is quite common in premenopausal women, particularly those between the ages of 18 and 39 years. Women in this age group were most likely to report that their FSD was severe, with lubrication disorders being the most common disturbance. Compared to those who did not endorse problems with lubrication, women with lubrication disorders had close to 50 times the odds of reporting moderate/severe sexual dysfunction. These findings are similar to those reported by Imbeah et al \[[@pone.0226404.ref021]\], who reported that 72% of Ghanaian women surveyed in their six region study, cited lubrication difficulties as causes of their dysfunctions. The root cause of FSD for these "young" women may have less to do with age and/or biological changes in hormonal regulation, and are most likely attributable to the physical/mechanical stress imposed on the vaginal tissue during sexual encounters. For women, vaginal lubrication is an important part of sex \[[@pone.0226404.ref066]\]. Lubrication readies the vagina for penetration, and reduces any accompanying friction or irritation during intercourse \[[@pone.0226404.ref004], [@pone.0226404.ref066], [@pone.0226404.ref067]\]. Without adequate lubrication, the frictional force imposed on the delicate vaginal tissue can result in bruising and tearing \[[@pone.0226404.ref066]\], which may lead to infections, painful sexual experiences and overall dissatisfaction with sex. Not surprisingly, lubrication, pain and satisfaction were the three FSD domains most associated with FSD severity in our study. And although sexual pain was the only statistically significant predictor of FSD-associated care seeking behavior, likely at the root of the woman's dyspareunia is inadequate lubrication. Though lubrication usually occurs naturally, some women become more lubricated than others \[[@pone.0226404.ref066]\]. It is important that women and their partners understand the role that lubrication plays in comfortable intercourse to reduce the woman's susceptibility for infections, as well as their painful sexual experiences. More studies are needed to evaluate the access, utilization and perception of personal lubricants amongst Ghanaian women and couples.

In our study, Women with FSD often normalized their dysfunctions, with one in three women indicating that they did not know that FSD was a medical condition and 14% noting that a healthcare provider would not be able to resolve their issue. These results again echo the findings of Imbeah and team \[[@pone.0226404.ref021]\] who indicated that 50%(n = 80) of the women in their study did not seek help because they were under the impression that FSD was normal, and 19.2% (n = 31) were embarrassed to seek help. Through targeted educational efforts, Ghanaian women should be made aware that persistent or recurring decreases in a woman's sexual desire, sexual arousal, painful sex (dyspareunia) and/or difficulty in or inability to achieve orgasm \[[@pone.0226404.ref007], [@pone.0226404.ref017]\] is a medical condition that can be treated by healthcare providers. This awareness raising is necessary, given that 82.4% of those who sought help in our study point to *emotional strain* as their reasons for seeking care for their sexual dysfunction. These women fit the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria for the clinical diagnosis of FSD \[[@pone.0226404.ref003], [@pone.0226404.ref068]--[@pone.0226404.ref070]\], and would require referral and treatment by an appropriate healthcare provider. Appropriately, most women in our study sought formal help from a General Practitioner (GP) or a Gynecologist for their conditions.

Ghana, like most countries, is undergoing a gender redistribution of the physician workforce \[[@pone.0226404.ref071]--[@pone.0226404.ref074]\]. The estimated 1:8,481 patient to provider ratio \[[@pone.0226404.ref075]\] has traditionally tipped in favor of male doctors \[[@pone.0226404.ref076]--[@pone.0226404.ref079]\], including Obstetric/Gynecologists (ObGyns) \[[@pone.0226404.ref080]\], even though there is ample literature to support the notion that women, particularly those in conservative cultures, prefer female OB-GYNs, given the intimacy of the services rendered by these providers \[[@pone.0226404.ref081]--[@pone.0226404.ref083]\]. Research shows that when patients are treated by physicians "who look like them" or have life experiences that closely match that of their patients', patients perceive their care to be of higher quality, are more satisfied with their care, have greater adherence to medical advice, and overall, have better health outcomes \[[@pone.0226404.ref084]--[@pone.0226404.ref088]\]. Providers also show a preference for same-gender consultations for sexual health matters \[[@pone.0226404.ref089]\].The global trend towards feminization of the healthcare workforce promises to bring changes to the patient--physician relationship, the local delivery of care, the global delivery of care to the society as a whole, as well as to the medical profession itself \[[@pone.0226404.ref072], [@pone.0226404.ref074]\]. Female physicians it has been shown, spend more time with their patients \[[@pone.0226404.ref072], [@pone.0226404.ref074], [@pone.0226404.ref090]\], write fewer prescriptions and are more attuned to their patients' needs enough to refer more cases to specialists than their male colleagues \[[@pone.0226404.ref072], [@pone.0226404.ref074], [@pone.0226404.ref091]\]. The female patient may be more comfortable raising sexual concerns with a female physician. There is however, a glaring male dominance of the ObGyn specialty in Ghana, with less than 10% female representation among practicing gynecologists \[[@pone.0226404.ref092]\]. Improving the gender balance of the Ghanaian physician workforce would decrease the patient:provider gender mismatch, and potentially improve discussions around the traditionally taboo details of female sexuality. Feminization could result in more women being screened by their GPs, and referred to ObGyns for proper diagnosis and treatment. Gender redistribution of Ghanaian doctors is a necessary step in reducing the "personal embarrassment" associated with women's reluctance to seek help for their sexual dysfunctions, as reported by our study participants. More female doctors are needed to provide care for the majority female Ghanaian population \[[@pone.0226404.ref035]\] and serve the needs and priorities of the health system. Transitioning to this model of care however, may take a long time to achieve, as it requires not only an attitudinal and cultural shift in the existing healthcare infrastructure, but may also require a dismantling of pre-existing institutional and structural barriers. Bridging this transition, may be a healthcare model that utilizes Advanced Practice Providers (APPs) such as nurse midwives, who often serve as primary caregivers for patients with obstetric and gynecological needs. Not only is the provider:patient ratio higher for these APPs, but the gender balance between patients and providers is not as disproportional. Nurse midwives could be trained to screen for FSD as part of their "routine" patient care; relieving the workload expectations of other providers.

In spite of these healthcare workforce trends, providers, male or female, should be made aware of and encouraged to discuss sexual health and sexual dysfunctions with their patients. Insufficient assessment of sexual health concerns by Physicians, is at the core of the barriers against appropriate diagnosis and outcome of FSD. Literature has emphasized the inconsistent and avoidant approach by providers to exploring women's sexual concerns \[[@pone.0226404.ref026], [@pone.0226404.ref093], [@pone.0226404.ref094]\]. Often times, the burden of reporting embarrassing symptoms and diagnosing of a dysfunction is shifted to the patient \[[@pone.0226404.ref026], [@pone.0226404.ref089], [@pone.0226404.ref095], [@pone.0226404.ref096]\]. The physician is often unintentionally constrained by multifaceted reasons, prominent among which is confidence in assessment skills. In Ghana, the ObGyn is expected in most cases, to deal with female reproductive and sexual health concerns. Hence the GP and other providers rarely explore detailed sexual history or lack proactivity and social empathy for discussing and identifying clients with sexual health needs. In addition to raising the awareness of patients about the detriments of FSD, there is a corresponding need to improve social empathy, assessment and management skills of Ghanaian physicians, particularly non-ObGyns, who often serve as the first point of contact for patients suffering from the condition.

Because of the social stigma around female sexuality, women tend to avoid and/or are embarrassed to discuss their sexual health with their health care professionals (HCPs) \[[@pone.0226404.ref094]\]. HCPs-both physicians and APPs-can be trained to improve their empathetic responses to their patients' sexual frustrations by initiating (and maintaining) a sexual health conversation in a manner that is comfortable for the woman to convey her concerns. This initial step is crucial to the trust building necessary for the trained provider to assess the patient, diagnose, treat and manage their FSD \[[@pone.0226404.ref089], [@pone.0226404.ref093], [@pone.0226404.ref094]\]. These tools-educating women, training HCPs, and providing communication tools to HCPs-may serve to decrease the stigma associated with sexual health discussions, and facilitate the treatment-oriented dialogue between patients and their providers when dealing with FSDs \[[@pone.0226404.ref094]\].

Strengths and limitations {#sec021}
=========================

This study, to our knowledge is the first of its kind in the rural-savannah, agro-ecological zone of Ghana's Volta region. Even though most of the study participants were recruited from the Gynecological and General Outpatient departments, we had representation from women in the Surgical, Dental, Ear/Nose/Throat and Ophthalmology departments as well. Our study did not exclude single women, or women who were not in heterosexual relationships, making our findings generalizable to a broad reach of Ghanaian women with varying sexual and relationship experiences. Despite these strengths, our study has a few limitations that bear mentioning. Firstly, restricting the study to women 18 years and older limits the generalizability of our findings to females below this age, particularly teenagers, whose sexual health tends to be under-studied in the Ghanaian context. The sexual experiences of the average Ghanaian teenager may be higher and more likely to be deemed "immoral" \[[@pone.0226404.ref019]\] than that of the "older" female; putting such adolescents at greater risk for gynecological infections, psychological distress and other FSD-related sequelae. More research is needed to better understand the impact of sexual dysfunctions across the spectrum of a Ghanaian woman's reproductive years. Another limitation of our study is in the sample size limitations imposed upon our analyses. Even though the study was well powered at a prevalence estimate of 72%, the low prevalence of moderate/severe FSD (27.6%, n = 40) resulted in wide and imprecise confidence intervals for the effect estimates in our adjusted analyses. This estimate, as discussed earlier, is likely over-estimated and reflects the prevalence amongst a care-seeking subpopulation of urology patients. The prevalence rate of our sample is in line with other non-clinical Ghanaian populations \[[@pone.0226404.ref018], [@pone.0226404.ref021]\], and also in range with global FSD prevalence estimates \[[@pone.0226404.ref007]\]. Studies that are powered at the lower prevalence estimates of our findings may yield more robust results from larger studies, that reflect the true population estimates. Such studies are needed to replicate and validate the current findings. Finally, our study does not account for differences in FSD outcomes based on the women's pregnancy status or sexual preferences. Though the FSFI was designed to be used non-discriminately, and has in fact been used to evaluate FSD outcomes in pregnant and non-pregnant heterosexual, lesbian and bisexual populations \[[@pone.0226404.ref013], [@pone.0226404.ref097]--[@pone.0226404.ref099]\], because we do not explicitly compare outcomes within these subgroups in our study, the findings should be interpreted cautiously. As is common in most sexuality studies, our results may be more reflective of a heterosexual majority and/or those with less conservative sexual attitudes and values \[[@pone.0226404.ref004], [@pone.0226404.ref100]\], than that of sexual minorities and/or others with conservative sexual attitudes. This is particularly salient in a country like Ghana, where overt discussions of sexual matters are frowned upon \[[@pone.0226404.ref015]\]. Those who are most reticent about sexual issues may be most vulnerable to adverse sexual outcomes, and may require greater clinical interventions. Thus future studies should attempt to evaluate FSD outcomes in pregnant Ghanaian women, as well as non-heterosexual individuals, who may have these and other unique challenges. Future research endeavors should also consider qualitative research methodologies that will better contextualize and support the study findings, through the use of narratives and theoretical frameworks. The contribution of this paper may be better appreciated if it were supported with qualitative theories/frameworks/models.

Conclusions {#sec022}
===========

The study's main objective was to describe the prevalence and severity of female sexual dysfunction (FSD) amongst a group of Ghanaian women in the outpatient setting of the predominantly rural Volta region of Ghana. Additionally we determine the predictors of FSD severity and care seeking behaviors of women with the condition.

We found that FSD is highly prevalent amongst women in rural settings of the Ghanaian community, with lubrication, pain and satisfaction disorders being the most associated with severity. These conditions leave women vulnerable to preventable sexually transmitted infections, physical pain and psychological distress. Most women deem the dysfunctions to be normal, and are unaware that FSD is a clinically diagnosable condition that can be treated by expert physicians. In order to attain the World Health Organization's agenda of "Health for All" by the year 2030 \[[@pone.0226404.ref101], [@pone.0226404.ref102]\], sexual dysfunctions should be incorporated into Ghana's national health agenda to improve the health of some of the most vulnerable members of Ghanaian society.

Appendix {#sec023}
========

DATA COLLECTION TOOL {#sec024}
--------------------

**FEMALE SEXUAL DYSFUNCTION: PREVALENCE AND HELP- SEEKING BEHAVIOUR AMONG WOMEN ATTENDING THE HO TEACHING HOSPITAL OUT--PATIENT DEPARTMENT**.

**Section A**

**Demographic Data of Participant**

**Part A**

A1. AGE: ...........................

A2. MARITAL STATUS: single (), married (), cohabiting (), deceased ()

A3.RELIGIOUS AFFILIATION: Christianity () Islam () others ()

A4.EDUCATIONAL LEVEL: no education () JHS () High School () Tertiary ()

A5.EMPLOYMENT STATUS: employed () unemployed ()

A6.OCCUPATION.......................................

A7.AVERAGE MONTHLY INCOME: GHS.............

A8.NUMBER OF CHILDREN ................

A9.NUMER OF DEPENDANTS...................

A10.PLACE OF RESIDENCE................................

A11.CLINIC SPECIALTY (OPD in what specialty)................................................

**Part B**

**B1. Over the past 4 weeks, how often did you feel sexual desire or interest?**

5 = Almost always or always

4 = Most times (more than half the time)

3 = Sometimes (about half the time)

2 = A few times (less than half the time)

1 = Almost never or never

**B2. Over the past 4 weeks, how would you rate your level (degree) of sexual desire or interest?**

5 = Very high

4 = High

3 = Moderate

2 = Low

1 = Very low or none at all

**B3. Over the past 4 weeks, how often did you feel sexually aroused (\"turned on\") during sexual activity or intercourse?**

0 = No sexual activity

5 = Almost always or always

4 = Most times (more than half the time)

3 = Sometimes (about half the time)

2 = A few times (less than half the time)

1 = Almost never or never

**B4. Over the past 4 weeks, how would you rate your level of sexual arousal (\"turn on\") during sexual activity or intercourse?**

0 = No sexual activity

5 = Very high

4 = High

3 = Moderate

2 = Low

1 = Very low or none at all

**B5. Over the past 4 weeks, how confident were you about becoming sexually aroused during sexual activity or intercourse?**

0 = No sexual activity

5 = Very high confidence

4 = High confidence

3 = Moderate confidence

2 = Low confidence

1 = Very low or no confidence

**B6. Over the past 4 weeks, how often have you been satisfied with your arousal (excitement) during sexual activity or intercourse?**

0 = No sexual activity

5 = Almost always or always

4 = Most times (more than half the time)

3 = Sometimes (about half the time)

2 = A few times (less than half the time)

1 = Almost never or never

**B7. Over the past 4 weeks, how often did you become lubricated (\"wet\") during sexual activity or intercourse?**

0 = No sexual activity

5 = Almost always or always

4 = Most times (more than half the time)

3 = Sometimes (about half the time)

2 = A few times (less than half the time)

1 = Almost never or never

**B8. Over the past 4 weeks, how difficult was it to become lubricated (\"wet\") during sexual activity or intercourse?**

0 = No sexual activity

1 = Extremely difficult or impossible

2 = Very difficult

3 = Difficult

4 = Slightly difficult

5 = Not difficult

**B9. Over the past 4 weeks, how often did you maintain your lubrication (\"wetness\") until completion of sexual activity or intercourse?**

0 = No sexual activity

5 = Almost always or always

4 = Most times (more than half the time)

3 = Sometimes (about half the time)

2 = A few times (less than half the time)

1 = Almost never or never

**B10. Over the past 4 weeks, how difficult was it to maintain your lubrication (\"wetness\") until completion of sexual activity or intercourse?**

0 = No sexual activity

1 = Extremely difficult or impossible

2 = Very difficult

3 = Difficult

4 = Slightly difficult

5 = Not difficult

**B11. Over the past 4 weeks, when you had sexual stimulation or intercourse, how often did you reach orgasm (climax)?**

0 = No sexual activity

5 = Almost always or always

4 = Most times (more than half the time)

3 = Sometimes (about half the time)

2 = A few times (less than half the time)

1 = Almost never or never

**B12. Over the past 4 weeks, when you had sexual stimulation or intercourse, how difficult was it for you to reach orgasm (climax)?**

0 = No sexual activity

1 = Extremely difficult or impossible

2 = Very difficult

3 = Difficult

4 = Slightly difficult

5 = Not difficult

**B13. Over the past 4 weeks, how satisfied were you with your ability to reach orgasm (climax) during sexual activity or intercourse?**

0 = No sexual activity

5 = Very satisfied

4 = Moderately satisfied

3 = About equally satisfied and dissatisfied

2 = Moderately dissatisfied

1 = Very dissatisfied

**B14. Over the past 4 weeks, how satisfied have you been with the amount of emotional closeness during sexual activity between you and your partner?**

0 = No sexual activity

5 = Very satisfied

4 = Moderately satisfied

3 = About equally satisfied and dissatisfied

2 = Moderately dissatisfied

1 = Very dissatisfied

**B15. Over the past 4 weeks, how satisfied have you been with your sexual relationship with your partner?**

5 = Very satisfied

4 = Moderately satisfied

3 = About equally satisfied and dissatisfied

2 = Moderately dissatisfied

1 = Very dissatisfied

**B16. Over the past 4 weeks, how satisfied have you been with your overall sexual life?**

5 = Very satisfied

4 = Moderately satisfied

3 = About equally satisfied and dissatisfied

2 = Moderately dissatisfied

1 = Very dissatisfied

**B17. Over the past 4 weeks, how often did you experience discomfort or pain during vaginal penetration?**

0 = Did not attempt intercourse

1 = Almost always or always

2 = Most times (more than half the time)

3 = Sometimes (about half the time)

4 = A few times (less than half the time)

5 = Almost never or never

**B18. Over the past 4 weeks, how often did you experience discomfort or pain following vaginal penetration?**

0 = Did not attempt intercourse

1 = Almost always or always

2 = Most times (more than half the time)

3 = Sometimes (about half the time)

4 = A few times (less than half the time)

5 = Almost never or never

**B19. Over the past 4 weeks, how would you rate your level (degree) of discomfort or pain during or following vaginal penetration?**

0 = Did not attempt intercourse

1 = Very high

2 = High

3 = Moderate

4 = Low

5 = Very low or none at all

**Part c**

**C1.Did you seek for help when you experienced the female sexual dysfunction?**

Yes \[\] No \[\]

**C2. If no to C1, why didn't you seek for help?**

Health provider cannot help me \[\] time constraints \[\]

Others....................................

**c3. If yes to C1, where did you seek help from?**

Gynecologist () general practitioner () Herbalist () friends () family () Prayer camp ()

Others.....................

**C4. If yes to C1, why did you seek help?**

Advised to by relatives/friends/pastor \[\] Referred from a formal healthcare personnel \[\] condition is causing relationship/marriage strains \[\] condition is causing emotional strains \[\]

Others............................................................

Supporting information {#sec025}
======================

###### Female Sexual Dysfunction Data_Deidentified for submission.

(ZIP)

###### 

Click here for additional data file.
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1\. Please amend your current ethics statement to address the following concerns:  

a\) Did participants provide their written or verbal informed consent to participate in this study?

b\) If consent was verbal, please explain i) why written consent was not obtained, ii) how you documented participant consent, and iii) whether the ethics committees/IRB approved this consent procedure.
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Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Partly

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

2\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

3\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: Dear Authors:

I have read your interesting paper which examines how women view FSD and the care seeking behaviours of women with the condition. I like the topic and I like the paper. I think the paper is underdeveloped. The paper will benefit significantly from a major revision. Some specific comments to improve the paper:

The introductory part of the paper needs to be reworked. The long expose is not connected to the subsequent paragraphs and detracts from texts. The transitioning between the first and second paragraph of the introduction is poor. The authors defined sexuality and straightaway discussed poor sexual functioning without first establishing a link between sexuality and sexual functioning.

One primary concern is how concepts are used very \'vaguely\' and not contextualized. Authors failed to tell the reader what is poor/sexual functioning? What do these terminologies mean? What is poor sexual functioning? Can you cite this concept? What does it entail exactly? Do men have poor sexual dysfunction too?

It will be useful to review the factors accounting for sexual dysfunction particularly in the West African context. Is it sociocultural beliefs/practices, anatomical/hereditary, or lifestyle (e.g., alcohol use, smoking, etc.) especially as the central focus of the study was to describe the predictors of FSD severity. Literature is missing on this? Provide some context regarding this.The following publications may help:

Anarfi, J. K., & Owusu, A. Y. 2011. "The Making of a Sexual Being in Ghana: The State, Religion and the Influence of Society as Agents of Sexual Socialization." Sexuality & Culture 15: 1--18.

Fiaveh, D. Y., Izugbara, C. O., Okyerefo, M. P. K., Reysoo, F., & Fayorsey, C. K. 2015. Constructions of masculinity and femininity and sexual risk negotiation practices among women in urban Ghana. Culture, Health & Sexuality, 17(5), 650-662.

Fiaveh, D. Y., Okyerefo, M. P. K., & Fayorsey, C. K. 2015. Women's experiences of sexual pleasure in Ghana. Sexuality & Culture, 19(4), 697-714.

The subsection on study setting provides little context to the study. For example, how do population size and per capita income relate to FSD? These were not evident in the demographic attributes presented in Table 1 under the results. The issues that matter (age, relationship/love, educational attainment, religion, employment status, etc.) were not emphasised in the review/introduction. Yet, they appear instrumental in the analysis/results and discussion. For example, the study found a significant relationship between a woman\'s age and FSD outcome. What does this mean? Would you suggest that younger (say those below age 40) women have different SDs from older women (those above 40 but below 60)?

Some more details about the methodology is required---ethical protocol and procedure/techniques. Was the survey face-to-face? Under what condition where the questionnaires administered? More clarity about the local dialect used since Ewe is not the only local language in the Volta region of Ghana. How were translations/transliterations done? Sexuality is a sensitive issue across 'borders' and since the questionnaires were administered by trained study personnel, further details about the processes/techniques could be useful. See:

Fiaveh, D. Y. (2018). Cultural sensitivities: A case study of sexual pleasure in Ghana. Sage Research Methods Cases, 9781526429780. <http://dx.doi.org/10.4135/9781526429780>.

Another point that deserves much clearer attention and may be an interesting facet of the point above are the measurements--- variables. How do relationship status or residential setting or religious affiliation directly impact FSD? And how do we measure these? On the basis of some typology developed, i.e., using a questionnaire? For example, how would different units of analysis in the sample, e.g., pregnant women, non pregnant women, women with kids/children and/or certain number of children, and non-heterosexual women impact the results/claims? How does sexuality operate in Ghanaian society that might silence or closet FSD? Does compulsory heterosexuality (penovaginal \'penetrative\' sex) rely upon FSF/D? The FSFI questionnaire has major flaws in \'todays\' Ghana. Since the paper is on rural agrarian setting in a surfer of Ghana, a section on limitation will be useful.

The items measured, i.e., desire, arousal, lubrication, orgasm, satisfaction, and pain during sexual intercourse do not suffice to make generalizations. If women desire pleasurable and safe sex, should't we be discussing/asking what role sexual preference/orientation (e.g., oral sex, use of condom) play in this? What about sex positions, romance, the penis; size, length, girth, etc., for those who prefer \'penetrative\' sex play in FSD? If not why not?

The results reflect the methods employed in the data gathered. Narratives were missing and this is 'sad'. There is need for some qualitative data, interviews, to support positivists' stance and claims being made in the paper including the proposal to develop contextually appropriate interventions for the subpopulation studied in Ghana. Would the results differ among Akan groups/speakers?

While the discussion is logically organised, it is underdeveloped probably due to the absence of a theory/framework to hold the arguments together. The contribution of this paper will be better appreciated if it were supported with a theory/framework/model.

The part about the link to rural residential setting and implications for FSD (see paragraph 1 line 9-12 under Discussion) is contested and can constitute a sensitive research design including stereotype. Is this a finding or an existing literature? If this is so, this should also be interrogated. This could be due to negative skewness in the sampling technique. You need to engage the data a bit more closely and situate your argument within a paradigm.

There are language problems and sloppiness. The authors need to proofread the paper thoroughly.

All my very best!

Reviewer \#2: I am impressed by this manuscript, both by the topic it studies, which I am sure is under studied in all settings, but especially in low resource settings such as Ghana, and by the quality of the paper.

I have just a few comments which are necessary to address before this paper can be published.

1\. The methods section doesn\'t ever state which inferential statistics are performed. The regression analyses need to be explained.

2\. Did interviewers only ask the questions about care-seeking to those women who answered in the affirmative about having symptoms of FSD?

3\. It is written, \"amongst women with FSD, the most commonly endorsed domains were\...\" What is meant by \"endorsed\"?

4\. Why is Table 3 only unadjusted estimates? Why aren\'t there multivariate analyses conducted on these data?

5\. I would caution the authors against the causal language at the beginning of the discussion section. \"This is the first study\...that evaluates the predictors\....\" These are associations, not predictors, since the data are all cross-sectional.

6\. The end of the first paragraph in the discussion section clearly lay out the problems that SD poses for women. Is it possible to state a few interventions that could address these? The authors go into some of them later in the discussion section, but it feels like that could be a good place for some information as well.

7\. While I do not disagree that a more gender equitable physician workforce would likely help with this, and other, issues (and I appreciate very much the authors going into some detail as to the advantages of having a gender equitable physician workforce), a) that is going to take a very long time to achieve, and b) all physicians \*should\* be able to address the health concerns of their patients. The authors do say that there is a need to improve \"social empathy, assessment and management\", but don\'t say if there are other ways that have proven effective to help physicians help their patients.

8\. In addition to what I wrote above, the authors also did not mention nurses or midwives, who are both far more plentiful in the country, and far more likely to be female. Is there a role for nurses and / or midwives in this space?

\*\*\*\*\*\*\*\*\*\*

6\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: Yes: Daniel Yaw Fiaveh

Reviewer \#2: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.
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Author response to Decision Letter 0

21 Oct 2019

Editor Comment

Please include the following items when submitting your revised manuscript:

Please amend your current ethics statement to address the following concerns:

a\) Did participants provide their written or verbal informed consent to participate in this study?

Response

We have added the following to the Methods section (on page 9):

As specified and approved by the University of Health and Allied Science\'s Research Review Board, we obtained written consent from all participants to conduct this study.

b\) If consent was verbal, please explain i) why written consent was not obtained, ii) how you documented participant consent, and iii) whether the ethics committees/IRB approved this consent procedure.

Response

Not applicable

Response

c\) Once you have amended this/these statement(s) in the Methods section of the manuscript, please add the same text to the "Ethics Statement" field of the submission form (via "Edit Submission").

Response

We have amended the Ethics Statement with the statement above

"As specified and approved by the University of Health and Allied Science\'s Research Review Board, we obtained written consent from all participants to conduct this study. "

 

Reviewer 1

We are truly honored to have had our manuscript reviewed by Dr Yaw Fiaveh, whose work was used to partially inform the current study. Dr Fiaveh, being a qualitative researcher, uses a methodology that is heavily grounded in theory. As providers and implementation scientists, we use approaches that are rooted in quantitative, epidemiological methodologies to attempt to derive practical, clinically-driven solutions to the problem of female sexual dysfunction in the population of interest we surveyed. Our work is often informed by that of qualitative researchers such as Dr Fiaveh, but our interests, motivations, and end goals often diverge; as we, as practitioners, are more driven by patient diagnosing and treatment.

Bearing these differences in mind, we have attempted to address the concerns raised by Dr Fiaveh as noted below.

Comment 1

The introductory part of the paper needs to be reworked. The long expose is not connected to the subsequent paragraphs and detracts from texts. The transitioning between the first and second paragraph of the introduction is poor. The authors defined sexuality and straightaway discussed poor sexual functioning without first establishing a link between sexuality and sexual functioning. One primary concern is how concepts are used very \'vaguely\' and not contextualized. Authors failed to tell the reader what is poor/sexual functioning? What do these terminologies mean? What is poor sexual functioning? Can you cite this concept? What does it entail exactly? Do men have poor sexual dysfunction too?

Response

We have modified the Introduction as follows (on pages 6-7):

The World Health Organization defines sexuality as a state of physical, emotional, mental and social well-being; a central aspect of "being human" that encompasses the possibility of having pleasurable and safe sexual experiences \[1, 2\]. Although sexual functioning is an essential aspect of human life, sexual problems are pervasive, and can result in severe consequences for the individual (and their partner) if not addressed. Sexual dysfunction, defined as difficulty experienced by an individual or a couple during any stage of a normal sexual activity, including physical pleasure, desire, preference, arousal or orgasm \[3, 4\] has been associated with depression and other common mental disorders, relationship discord, poor self-rated health, infertility and overall quality of life \[4-11\]. Per the published literature, the prevalence of sexual dysfunctions is extremely high, and ranges from 10-63% across various global populations \[7, 11-14\]. Sexual problems are often multifactorial and can be classified into four broad categories which are: biomedical (biological factors such as pregnancy, infertility, sexually transmitted infections, injury and disability, cardiovascular and other chronic diseases that can interfere with intercourse); intrapsychic (psychological elements within the individual, that influence their sexual expression e.g., values learned about one's body, nudity, "where babies come from", what to expect during puberty, etc); interpersonal (factors that influence one's ability to engage in sexual relationships, such as communication difficulties with a partner, distrust, power struggles, the extent to which partners share compatible visions of sex, eroticism, pleasure etc.); and socio-cultural/economic/political ('blueprints' for sexual norms, beliefs, values, practices and attitudes that are created and imposed on an individual based on the 'moral code' of their society. Includes religion, the state and the general established society. Less urban settings may have more conservative beliefs and practices about sexuality) \[4, 15\]. These four factors often overlap, and rarely occur in isolation to cause the dysfunction \[4\]. Though sexual dysfunctions are common in both sexes, the greatest morbidity has been reported in women, particularly those in the African region \[7\]. In many African cultures, the discussion of sexual issues is generally considered a taboo \[15, 16\]; with conversations of sexuality heavily focused on religion, "moral behavior" and abstinence \[15\]. The mere mention of sex is often synonymous with deviant behavior \[15\], suppressing discussions of sexuality as a whole, and sexual dysfunctions in particular. "

Have also added the following to the Discussion (pages 21-22):

"Human sexuality refers to 'the sum of the physical, functional, and psychologic attributes that are expressed by one's gender identity and sexual behavior \[15\]. Human sexuality goes beyond biological attributes, and includes overlapping constructs intrapsychic, interpersonal and socio-cultural/economic/political factors \[4, 15\]. In many parts of the world, sexuality is considered a sensitive topic, and sexual discussions-whether they be of displeasure or not, are discouraged. Female sexuality is especially taboo; particularly in religious countries like Ghana. Thus women with pathological disorders in sexual functioning may not seek and/or receive the diagnosis and treatment that they may need for their clinically diagnosable and treatable sexual disorders".

Comment 2

It will be useful to review the factors accounting for sexual dysfunction particularly in the West African context. Is it sociocultural beliefs/practices, anatomical/hereditary, or lifestyle (e.g., alcohol use, smoking, etc.) especially as the central focus of the study was to describe the predictors of FSD severity. Literature is missing on this? Provide some context regarding this. The following publications may help:

Anarfi, J. K., & Owusu, A. Y. 2011. "The Making of a Sexual Being in Ghana: The State, Religion and the Influence of Society as Agents of Sexual Socialization." Sexuality & Culture 15: 1--18.

Fiaveh, D. Y., Izugbara, C. O., Okyerefo, M. P. K., Reysoo, F., & Fayorsey, C. K. 2015. Constructions of masculinity and femininity and sexual risk negotiation practices among women in urban Ghana. Culture, Health & Sexuality, 17(5), 650-662.

Fiaveh, D. Y., Okyerefo, M. P. K., & Fayorsey, C. K. 2015. Women's experiences of sexual pleasure in Ghana. Sexuality & Culture, 19(4), 697-714.

Response

Thank you for the references, we have added content to the introduction and discussion sections as stated above in comment \#1

Comment 3

The subsection on study setting provides little context to the study. For example, how do population size and per capita income relate to FSD? These were not evident in the demographic attributes presented in Table 1 under the results.

Response

The details on study setting (population size and per capita income on page 8) are to geographically orient and contextualize the study to all non-Ghanaian and Ghanaian readers. Though this may not be directly related to FSD, we believe this information is important, and relevant to the PlosOne readership.

We are happy to modify with Dr Fiaveh's recommendations.

Comment 4

The issues that matter (age, relationship/love, educational attainment, religion, employment status, etc.) were not emphasised in the review/introduction. Yet, they appear instrumental in the analysis/results and discussion.

Response

We modified the introduction to account for these factors as noted in response to comment 1. Please keep in mind that our project was not meant to be a theoretical, anthropological undertaking. Rather, our project was informed by such published work, and sets the stage for exploring possible solutions to the issue of FSD in patient populations that we, as providers, are faced with in our everyday interactions with our patients.

Comment 5

For example, the study found a significant relationship between a woman\'s age and FSD outcome. What does this mean? Would you suggest that younger (say those below age 40) women have different SDs from older women (those above 40 but below 60)?

Response

We believe this issue of Age and FSD was addressed in the discussion as noted below (pages 21-22 of Discussion). As providers, it was important to find out from conducting this work, that lubrication disorders were the most severe form of FSD for "young" women in the study. This finding is important as the clinical "intervention" may be as simple as providing lubricants to our patients for whom this is an issue, to decrease the dysfunction. This is an important finding from a clinical/practitioner/implementation science perspective.

The following can be found on pages 23-24 of the Discussion:

"It is often assumed that sexual dysfunctions in women are associated with increasing age, the onset of menopause, and several associated hormonal changes \[5, 6, 13, 17-22\]. However, our results show that FSD is quite common in premenopausal women, particularly those between the ages of 18 and 39 years. Women in this age group were most likely to report that their FSD was severe, with lubrication disorders being the most common disturbance...

The root cause of FSD for these "young" women may have less to do with age and/or biological changes in hormonal regulation, and are most likely attributable to the physical/mechanical stress imposed on the vaginal tissue during sexual encounters. For women, vaginal lubrication is an important part of sex \[23\]. Lubrication readies the vagina for penetration, and reduces any accompanying friction or irritation during intercourse \[4, 23, 24\]. Without adequate lubrication, the frictional force imposed on the delicate vaginal tissue can result in bruising and tearing \[23\], which may lead to infections, painful sexual experiences and overall dissatisfaction with sex. Not surprisingly, lubrication, pain and satisfaction were the three FSD domains most associated with FSD severity in our study. And although sexual pain was the only statistically significant predictor of FSD-associated care seeking behavior, likely at the root of the woman's dyspareunia is inadequate lubrication. Though lubrication usually occurs naturally, some women become more lubricated than others \[23\]. It is important that women and their partners understand the role that lubrication plays in comfortable intercourse to reduce the woman's susceptibility for infections, as well as their painful sexual experiences. More studies are needed to evaluate the access, utilization and perception of personal lubricants amongst Ghanaian women and couples.

Comment 6

Some more details about the methodology is required---ethical protocol and procedure/techniques.

Response

We added the following to the methods section (page 10):

"As specified and approved by the University of Health and Allied Sciences' Research Ethics Committee, we obtained written consent from all participants to conduct this study. All consent forms were kept separately from the de-identified survey questionnaires, in a secure location under the supervision of the final author. Keeping the signed consents separate from the survey questionnaires was to ensure that participants' responses could not be connected to their identities."

Comment 7

Was the survey face-to-face?

Response

As noted on page 11:

"All surveys were interviewer led and completed in-person with each respondent."

We have added "face-to-face" to be more specific

"All surveys were interviewer led and completed in-person (i.e. face-to-face) with each respondent."

Comment 8

Under what condition where the questionnaires administered?

Response

We have added the following on page 12:

"All interviews were conducted in a screen-protected and discrete study-designated area of the outpatient departments of the Ho Teaching Hospital where the study was conducted... We pretested the survey in the following two steps: i) Interviewing of random respondents within the Ho Teaching Hospital to determine participants' language preferences and to ensure uniformity among study personnel, and 2) under the supervision of the senior author (BI), interviewers practiced administering the survey to ensure consistency of delivery and translation of questions by all study personnel.

Comment 9

More clarity about the local dialect used since Ewe is not the only local language in the Volta region of Ghana. How were translations/transliterations done? Sexuality is a sensitive issue across 'borders' and since the questionnaires were administered by trained study personnel, further details about the processes/techniques could be useful.

Response

We added the following to the document (page 12)

"Though there are many languages spoken in the Volta region, from our training and pre-testing phases preparatory to the study, we found most respondents could comfortably speak Ewe, Twi, English or combinations of these. We pretested the survey in the following two steps: i) Interviewing of random respondents within the Ho Teaching Hospital to determine participants' language preferences and to ensure uniformity among study personnel, and 2) interviewers practice administering the survey to other trainees to ensure consistency of delivery and translation of questions by all study personnel."

Comment 10

Another point that deserves much clearer attention and may be an interesting facet of the point above are the measurements--- variables. How do relationship status or residential setting or religious affiliation directly impact FSD? And how do we measure these? On the basis of some typology developed, i.e., using a questionnaire?

Response

We hope the enhancements we added to the introduction and discussion pages of the manuscript (Reponses to Comment \#1) address this comment as well. We have also added the approved questionnaire we used in the study as an appendix. We reference the reader to see the appendix as noted below and on page 10 of the manuscript:

"Data Collection Instrument & Measures

Demographics

A standard questionnaire (see Appendix) was used to collect socio-demographic data about participants' demographic ..."

Comment 11

For example, how would different units of analysis in the sample, e.g., pregnant women, non pregnant women, women with kids/children and/or certain number of children, and non-heterosexual women impact the results/claims? How does sexuality operate in Ghanaian society that might silence or closet FSD? Does compulsory heterosexuality (penovaginal \'penetrative\' sex) rely upon FSF/D?

Response:

In addition to the changes made to the introduction and discussion (comment \#1) to address these comments, We have also added the following to the Discussion section on the study's limitations section (pages 28-29) to address this comment in particular:

"How does sexuality operate in Ghanaian society that might silence or closet FSD?"

"Finally, our study does not account for differences in FSD outcomes based on the women's pregnancy status or sexual preferences. Though the FSFI was designed to be used non-discriminately, and has in fact been used to evaluate FSD outcomes in pregnant and non-pregnant heterosexual, lesbian and bisexual populations \[13, 25-27\], because we do not explicitly compare outcomes within these subgroups in our study, the findings should be interpreted cautiously. As is common in most sexuality studies, our results may be more reflective of a heterosexual majority and/or those with less conservative sexual attitudes and values \[4, 28\], than that of sexual minorities and/or others with conservative sexual attitudes. This is particularly salient in a country like Ghana, where overt discussions of sexual matters are frowned upon \[15\]. Those who are most reticent about sexual issues may be most vulnerable to adverse sexual outcomes, and may require greater clinical interventions. Thus future studies should attempt to evaluate FSD outcomes in pregnant Ghanaian women, as well as non-heterosexual individuals, who may have these and other unique challenges. Future research endeavors should also consider qualitative research methodologies that will better contextualize and support the study findings, through the use of narratives and theoretical frameworks."

Comment 12:

The FSFI questionnaire has major flaws in \'todays\' Ghana. Since the paper is on rural agrarian setting in a surfer of Ghana, a section on limitation will be useful.

Response:

Since its inception in 2000 by Rosen et al, the FSFI has been used extensively to evaluate sexual outcomes in a variety of female populations as noted in our comment above (pregnant, non-pregnant, heterosexual, lesbian, bisexual, etc etc). We selected that instrument because 1) it does not require individuals to be in heterosexual relationships (unlike the Golombok-Rust Inventory of Sexual Satisfaction (GRISS)) which was used in the Amidu study in Ghana \[29, 30\]; 2)it has been used in several culturally sensitive populations \[25, 31-33\], and is not explicit (like the Derogatis Interview for Sexual Function-Self Report (DISF-SR) and others)\[28\]; 3) it allows for comparison of the results across the published literature, with other African and non-African populations \[7, 13\], and 4) most importantly, the instrument has clinical relevance and conforms with the DSM-V classifications; which we, as practitioners, deem important \[34\].

Preparatory to the research, as noted in the manuscript (comment \#9), we pre-tested the instrument with patients to assess their comfort, we ensured that study personnel were also consistent in the survey administrations, we consulted with various other Ghanaian quantitative researchers in this field (Samuel Oppong \[35\]), CharlesTakyi (Erica Goldstein and Charles Takyi, Female Sexual Dysfunction:Prevalence and Risk in Ghana. November 2015: Physicians For Human Rights National Student Conference) prior to selecting the FSFI as the most appropriate tool for our study's purpose and clinical/implementation science agenda.

Interestingly, we found no issues with using this instrument in today's Ghana, particularly with our Volta participants who we would have expected to be less forthcoming than those in more urban areas like Accra or Kumasi. Our pre-test activities informed us well on how the study would be received-and it was a positive one. Out of 407 women approached, 83.8% agreed to participate in the study.

Questions in the FSFI seem to have transcended time and populations. Today's Ghana is less conservative, with the portrayal of Ghana's female sexuality on shows such as Christiane Amanpour's sex and love which was viewed all over the world (<https://qz.com/africa/1254088/cnn-ghana-and-moesha-boduong-spark-backlash-on-sex-love-and-african-women/>), women like Akumaa Mama Zimbi; Ghana's "Sex Doctor", openly discussing "bedroom wahala" on radio, television and social media.

We kindly request Dr Fiaveh to please clarify this comment as we may be misunderstanding what he means by the instrument has "major flaws in \'todays\' Ghana". For ease of reference, we have included the survey instrument in the Appendix of the manuscript on pages 28-32.

Comment 13

The items measured, i.e., desire, arousal, lubrication, orgasm, satisfaction, and pain during sexual intercourse do not suffice to make generalizations. If women desire pleasurable and safe sex, should't we be discussing/asking what role sexual preference/orientation (e.g., oral sex, use of condom) play in this? What about sex positions, romance, the penis; size, length, girth, etc., for those who prefer \'penetrative\' sex play in FSD? If not why not?

Response

We believe that Dr Fiaveh has covered much of these in his work \[36, 37\]

(Daniel Yaw Fiaveh, Condom Myths and Misconceptions: The Male Perspective. Global Journal of Medical research, 2012. 12(5).

Fiaveh, D.Y. and Michael PK Okyerefo, Femininity, Sexual Positions and Choice. Sexualities, 2019. 22(1-2): p. 131-147.

Fiaveh, D.Y. Phallocentricism, female penile choices, and the use of sex toys in Ghana <https://doi.org/10.1177/1363460718781975>)

and though we used some of this information to inform our work, our focus was not only to identify the pathological prevalence, but to determine the types of FSD (desire, arousal, lubrication, orgasm, satisfaction, and pain), and their severity from a clinical standpoint so we can incorporate these findings in clinical practice.

We acknowledge that these outcomes may not be generalizable nor are they comprehensive. However, we designed our study with the FSFI instrument to assist us in practically determining the prevalence of the various types of FSD designated in the DSM-V, in order to treat the distressed patient who seeks our care.

Penis size, sexual positions, oral sex and other aspects of sexual behavior/preferences though important, are not as important for us, as epidemiologists, clinicians and implementation scientists, as finding that (Page 5):

"Over a quarter of the sample (27.6%, n=40) met the cut-off for moderate to severe FSD. In age-adjusted models, lubrication disorder was associated with 45 times the odds of moderate/severe FSD (95% CI: 9.27, 264.5; p\<0.001), pain with 17times the odds (OR: 17.18, 95% CI: 4.50, 65.50; p\<0.001) and satisfaction almost 5times the odds (OR: 4.69, 95% CI: 1.09, 20.2; p=0.04)..."

Such a salient finding allows us to recognize the potentially debilitating consequences of the dysfunction on our patients. As an example, knowing that lubrication disorders are the most oppressive allows us to explore treatment options for the patient-options which, as previously mentioned, may be "simple" to implement. Relieving the frictional force imposed on the delicate vaginal tissue during penetrative intercourse can alleviate bruising and tearing, and reduce the woman's susceptibility to infections, painful sexual experiences and overall dissatisfaction with sex.

Oral sex, condom use, sex positions, romance, the penis; size, length, girth, etc., for those who prefer \'penetrative\' sex play etc. though important, would not sufficiently treat a woman's lubrication disorder. Treating that disorder, however, will enhance the woman's sexual experience each time she encounters her "preferred" penis: size, length, girth, etc; preferred sexual position; or preferred romancing.

Additionally, designing a study that focused primarily on penis preference and condom use would have been presumptive on our part, restricting the study's generalizability to participants with heterosexual preferences solely; an issue that Dr Fiaveh has already noted would not have been favorable; and that we have attempted very hard to avoid.

Comment 14

The results reflect the methods employed in the data gathered. Narratives were missing and this is 'sad'. There is need for some qualitative data, interviews, to support positivists' stance and claims being made in the paper including the proposal to develop contextually appropriate interventions for the subpopulation studied in Ghana.

Response:

We have added the following to the discussion (page 29)

"Future research endeavors should also consider qualitative research methodologies that will better contextualize and support the study findings, through the use of narratives and theoretical frameworks. "

Comment 15

Would the results differ among Akan groups/speakers?

Response

We sought to conduct this study in women in the Volta region because none of the existing literature has evaluated these outcomes in this region of Ghana. The six region study by Ibmeah and co \[35\] claimed to evaluate outcomes in a "representative" part of Ghana, but omitted Volta participants. The study included female participants from Greater Accra, Ashanti, Western, Central, Brong-Ahafo and Eastern regions but excluded the Volta region. Part of our agenda was to fill a gap in the literature and determine if findings from these 6 regions differ from that of Volta participants. What we found was that our findings are similar. Our estimate of 48.3% approximated the larger, more inclusive study's estimate of 45.6%

We have modified the sentence on page 22 of the manuscript to be more specific:

" The FSD prevalence estimate of 48.3% in our study, approximates the global prevalence of 40.9% \[7\] and is similar to rates reported for non-clinical, mostly urban Ghanaian females in heterosexual relationships (45.6%) who hailed from the Greater Accra, Ashanti, Western, Central, Brong-Ahafo and Eastern regions. \[35\]."

Comment 16

While the discussion is logically organised, it is underdeveloped probably due to the absence of a theory/framework to hold the arguments together. The contribution of this paper will be better appreciated if it were supported with a theory/framework/model.

Response:

Our study's aim, cited on page 6 of the manuscript, were to describe the prevalence and severity of FSD amongst a group of Ghanaian women in the outpatient setting of the predominantly rural Volta region of Ghana; and to describe the predictors of FSD severity and the care seeking behaviors of women with the condition.

In the results section (pages 13-21), we fulfill these aims by reporting the prevalence of FSD, the severity of the dysfunction and the care-seeking behaviors of our study participants.

We have also added this comment as an addition to the limitations section:

"Future research endeavors should also consider qualitative research methodologies that will better contextualize and support the study findings, through the use of narratives and theoretical frameworks. The contribution of this paper may be better appreciated if it were supported with qualitative theories/frameworks/models (page 26)."

Comment 17

The part about the link to rural residential setting and implications for FSD (see paragraph 1 line 9-12 under Discussion) is contested and can constitute a sensitive research design including stereotype. Is this a finding or an existing literature? If this is so, this should also be interrogated. This could be due to negative skewness in the sampling technique. You need to engage the data a bit more closely and situate your argument within a paradigm.

Response:

The statements in lines 9-12 of the discussion have been substantiated across the literature (including calls for intervention by the Ghana Ministry of Health for studies to improve outcomes in rural populations (Ministry of Health Ghana. Ghana Millenium Development Goals Acceleration Framework, 2015 Strategy and Operational Plan. Accra, Ghana2015.), other Ghanaian researchers

Amalba, A., et al. (2018). \"Working among the rural communities in Ghana - why doctors choose to engage in rural practice.\" BMC Med Educ 18(1): 133.

Development Initiatives 2018 (4/5/205). \"Ghana's rural savannah areas suffer persistently high poverty.\" Retrieved 8/1/2019, from <http://devinit.org/post/ghanas-rural-savannah-areas-suffer-persistently-high-poverty/>.

Bazzano, A.N., B. Kirkwood, C. Tawiah-Agyemang, S. Owusu-Agyei, and P. Adongo, Social costs of skilled attendance at birth in rural Ghana. Int J Gynaecol Obstet, 2008. 102(1): p. 91-4.

Kyei-Nimakoh M, Carolan-Olah M, McCann TV. Millennium development Goal 5: progress and challenges in reducing maternal deaths in Ghana. BMC pregnancy and childbirth. Mar 9 2016;16:51.)

And the American College of Obstetrics and Gynecology, the governing body for

Obstetricians and Gynecologists, the head of which is currently Dr Adanu, who, along

with Prof J.K Anarfi, J. K published one of the earliers papers on the Ghana Ministry of

Health's restrictive Sexual and Reproductive Health Strategy\[16\] )

It is also assuring that our study findings support the statements regarding participants in our study who described themselves as residing in rural setting. As we note in the discussion (page 14):

"Approximating the rural population of the Volta Region, over a third of the FSD women resided in rural settings (37.9% vs 20.6% p=0.001) and tended to be multiparous, with a significantly greater proportion having at least three children (31.7% vs 18.1; p=0.033), compared to those without FSD."

On a grander and more relevant scale, women in the Volta region have been traditionally missing from the Ghana FSD literature (see comment 15 above) and this study offers a unique opportunity for us, as implementation and research scientists to work with an under-represented population. Our sampling strategy was designed to answer the research question, and not intentionally skewed. We see our study design as an opportunity to give voice to those who have been omitted from the literature, rather than a stereotyping. We sought to ask a very specific research question (Page 8)

"In this paper, we describe the prevalence and severity of FSD amongst a group of Ghanaian women in the outpatient setting of the predominantly rural Volta region of Ghana. We describe the predictors of FSD severity and the care seeking behaviors of women with the condition; in the hopes of identifying possible opportunities for developing contextually appropriate interventions for this subpopulation of women.

And on pages 14-21 we answer those questions.

We implore Dr Fiaveh to see the gap that this study is filling, and the opportunity it presents for offering solutions for women who tend to be dismissed from such work. The large, six-region study by Imbeah and co \[35\] even excluded Volta residents.

As we state in the Discussion (page 21):

"This is the first study that to our knowledge, evaluates the prevalence, severity and help-seeking behaviors of women with FSD in the mostly rural and agrarian setting of the Volta region of Ghana."

Comment 18

There are language problems and sloppiness. The authors need to proofread the paper thoroughly.

Response

This comment is in direct contraction to the reviewer's response to item 4 on the review (see below). We ask Dr Fiaveh to please highlight such issues for our attention and correction.

4\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

Reviewer \#2: Yes

Comment 19

All my very best!

Response:

The honor is ours. We are grateful for your time

 

Reviewer \#2:

I am impressed by this manuscript, both by the topic it studies, which I am sure is under studied in all settings, but especially in low resource settings such as Ghana, and by the quality of the paper.

Response

Thank you for recognizing the amount of work we put into this work, which is near and dear to our hearts.

I have just a few comments which are necessary to address before this paper can be published.

Comment 1

1\. The methods section doesn\'t ever state which inferential statistics are performed. The regression analyses need to be explained.

Response

We discuss the univariate and bivariate analyses but realize that we did not touch on the regression models in the statistical analyses section. Thank you for noticing that.

We have added the following to the statistical analyses section on page 13:

"Age was found to be associated with several other covariates and predictors, and was the most significant predictor of FSD outcome in this study. Adjusting for age only in logistic regression analyses gave us the most parsimonious models. Thus in our logistic regression models, we present both crude and age-adjusted effect estimates. All computations were done at the 95% confidence level, and we report odds ratios and their associated 95% confidence intervals. We used p \<0.05 to determine statistical significance for all analyses."

Comment 2:

2\. Did interviewers only ask the questions about care-seeking to those women who answered in the affirmative about having symptoms of FSD?

Response

Care seeking behaviors were asked of all participants. Those who sought care (responded "Yes" to question c1) were asked where (c3) and why (c4) they sought help. Those who did no seek help ("No" to question c1 were asked why they did not seek help (c2). We have included the survey instrument in the appendix to orient the reader. We have also updated Table 3 (pages 20-21) with footnotes to orient the reader:

Part c

C1.Did you seek for help when you experienced the female sexual dysfunction?

Yes \[ \] No \[ \]

C2. If no to C1, why didn't you seek for help?

Health provider cannot help me \[ \] time constraints \[ \]

Others...........................................................

c3. If yes to C1, where did you seek help from?

Gynecologist ( ) general practitioner ( ) Herbalist ( ) friends ( ) family ( ) Prayer camp ( )

Others...........................

C4. If yes to C1, why did you seek help?

Advised to by relatives/friends/pastor \[ \] Referred from a formal healthcare personnel \[ \] condition is causing relationship/marriage strains \[ \] condition is causing emotional strains \[ \]

Others.....................................................................................................................

Have also added the following legend to table 3

\*asked of those who answered "Yes" to the question "Did you seek for help when you experienced the female sexual dysfunction?" (see Appendix)

\*\*asked of those who answered "No" to the question "Did you seek for help when you experienced the female sexual dysfunction?" (see Appendix)

Comment 3

3\. It is written, \"amongst women with FSD, the most commonly endorsed domains were\...\" What is meant by \"endorsed\"?

Response

Endorsed in this context is used for those who met the cutoff for the particular disorder. Thus women who endorsed pain disorders on Table 1 for example, met the cut-off for falling into the pain FSD category. Happy to replace if the reviewer could make a recommendation.

Comment 4

4\. Why is Table 3 only unadjusted estimates? Why aren\'t there multivariate analyses conducted on these data?

Response

We have updated this table with adjusted estimates, similar to Table 2. We also took this an opportunity to make relevant changes to the Results section, both text and tables.

Comment 5

5\. I would caution the authors against the causal language at the beginning of the discussion section. \"This is the first study\...that evaluates the predictors\....\" These are associations, not predictors, since the data are all cross-sectional.

Response

The sentence has been updated as follows:

This is the first study that to our knowledge, evaluates the prevalence, severity and help-seeking behaviors of women with FSD in the mostly rural and agrarian setting of the Volta region of Ghana.

Comment 6

6\. The end of the first paragraph in the discussion section clearly lay out the problems that SD poses for women. Is it possible to state a few interventions that could address these? The authors go into some of them later in the discussion section, but it feels like that could be a good place for some information as well.

Response

We added the following on page 23:

"The Ministry of Health's reproductive health policy could be expanded beyond the prevention of unwanted pregnancies and sexually transmitted infections \[15, 16, 30\] to more holistically encourage providers to discuss sexual health and sexual dysfunctions (both male and female forms) with their patients. We acknowledge that such a recommendation would require an enormous psycho-socio-cultural shift across all facets of the country's healthcare system, but without such a strategy, it will be difficult to recognize the discriminant impact that sexual dysfunctions have on some of the most vulnerable members of Ghanaian society."

Comment 7

7\. While I do not disagree that a more gender equitable physician workforce would likely help with this, and other, issues (and I appreciate very much the authors going into some detail as to the advantages of having a gender equitable physician workforce), a) that is going to take a very long time to achieve, and b) all physicians \*should\* be able to address the health concerns of their patients. The authors do say that there is a need to improve \"social empathy, assessment and management\", but don\'t say if there are other ways that have proven effective to help physicians help their patients.

Response

We have added the following to page 27:

Because of the social stigma around female sexuality, women tend to avoid and/or are embarrassed to discuss their sexual health with their health care professionals (HCPs) \[38\]. HCPs-both physicians and APPs-can be trained to improve their empathetic responses to their patients' sexual frustrations by initiating (and maintaining) a sexual health conversation in a manner that is comfortable for the woman to convey her concerns. This initial step is crucial to the trust building necessary for the trained provider to assess the patient, diagnose, treat and manage their FSD \[38-40\]. These tools-educating women, training HCPs, and providing communication tools to HCPs-may serve to decrease the stigma associated with sexual health discussions, and facilitate the treatment-oriented dialogue between patients and their providers when dealing with FSDs \[38\].

Comment 8

8\. In addition to what I wrote above, the authors also did not mention nurses or midwives, who are both far more plentiful in the country, and far more likely to be female. Is there a role for nurses and / or midwives in this space?

Response

This is a great point, Thank you. The following has been added on page 26:

"Transitioning to this model of care however, may take a long time to achieve, as it requires not only an attitudinal and cultural shift in the existing healthcare infrastructure, but may also require a dismantling of pre-existing institutional and structural barriers. Bridging this transition, may be a healthcare model that utilizes Advanced Practice Providers (APPs) such as nurse midwives, who often serve as primary caregivers for patients with obstetric and gynecological needs. Not only is the provider:patient ratio higher for these APPs, but the gender balance between patients and providers is not as disproportional. Nurse midwives could be trained to screen for FSD as part of their "routine" patient care; relieving the workload expectations of other providers."
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Comment

Reviewer \#1: Dear Authors,

I have read your revised paper and it reads better than the previous one. I feel the contribution of this study will be better appreciated if it were grounded in a theory/model.

Response

We addressed this comment in the limitations for future studies in the discussion section:

"Future research endeavors should also consider qualitative research methodologies that will better contextualize and support the study findings, through the use of narratives and theoretical frameworks. The contribution of this paper may be better appreciated if it were supported with qualitative theories/frameworks/models."

Minor issues:

Comment

• The sentence on sexual problems in response to Comment 1 in the introduction is long. You may want to reconsider for clarity.

Response

We have made some edits as follows (these are also tracked in the document):

Sexual problems are often multifactorial and can be classified into four broad categories, which are: biomedical (biological factors such as pregnancy, injury and disability, cardiovascular and other chronic diseases that can interfere with intercourse); intrapsychic (psychological elements within the individual, that influence their sexual expression e.g., values learned about one's body, nudity, "where babies come from", puberty, etc); interpersonal (factors that influence one's ability to engage in sexual relationships, such as communication difficulties with a partner, the extent to which partners share compatible visions of sex, eroticism, pleasure etc.); and socio-cultural/economic/political ('blueprints' for sexual norms, beliefs, values, practices and attitudes that are created and imposed on an individual based on the 'moral code' of their society. Includes religion.) \[4, 15\]. These four factors often overlap, and rarely occur in isolation to cause the sexual dysfunction \[4\].

Comment

• Since the term human sexuality is introduced in the work for the first time, I am not quite sure about the appropriateness of the current location, i.e., discussion (pages 21-22). In my view, it will better fit for the introduction.

Response

We revised the discussion to be more specific to sexual function and reads as follows:

Though human sexual function has requisite biological underpinnings, it is usually experienced as a complex interaction of biological, intrapsychic, interpersonal and socio-cultural/economic/political factors \[4, 15\].

Comment

• A recap of the main objective(s) in the first paragraph of the conclusion would be useful.

Response

We updated the conclusion to read as follows:

The study's main objective was to describe the prevalence and severity of female sexual dysfunction (FSD) amongst a group of Ghanaian women in the outpatient setting of the predominantly rural Volta region of Ghana. Additionally we determine the predictors of FSD severity and care seeking behaviors of women with the condition.We found that FSD is highly prevalent amongst women in rural settings of the Ghanaian community, with lubrication, pain and satisfaction disorders being the most associated with severity.

Comment

• It's surprising the authors find the suggestion to proofread the paper for clarity a contradiction to other segments of the online reviewer form. Overall assessment of an article (in relation to the intelligibility and writing standard) is not coterminous with specific errors noted in same.

Response

We must have misinterpreted the following comment by the reviewer:

"There are language problems and sloppiness\..."

Thank you for the clarification.

Comment

I want to commend the authors for the point-by-point responses to the specific issues raised in the article and I look forward to reading the published version. Thank you for your fine contribution.

All my very best!

Response

We appreciate your insights
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